On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new ...

The stent, called Absorb, releases everolimus, a drug that combats the formation of scar tissue to prevent the artery from narrowing again, according to the FDA. Unlike traditional stents made of ...

The Food and Drug Administration is warning clinicians that patients implanted with Abbott Laboratories’ Absorb dissolving stent may experience more heart issues than those implanted with the ...

(Reuters) - Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent with a ...

The drugmaker reported positive results from a first-stage U.S. trial of its ABSORB stent. The device slowly releases medicine to the heart and eventually dissolves. Abbott Laboratories' (NYSE:ABT - ...

WASHINGTON (AP) - A disappearing medical implant gets a closer look from the Food and Drug Administration this week. The FDA meets Tuesday to review Abbott Laboratories' first-of-a-kind heart stent ...

Abbot's heart stent, Absorb, is expected to attract significant adoption in the U.S. market if it gets FDA approval. Also, Abbott is in the process of getting approval in other bigger coronary stent ...

CONCORD, Calif. (KGO) -- Research being conducted here in the Bay Area could provide a major advance for heart patients. Surgeons at John Muir Medical Center in Concord are implanting patients with a ...

WASHINGTON – The field of bioabsorbable stents – sometimes described as bioresorbable stents – has yet to bloom despite the long historical presence of the Igaki-Tamai bioabsorbable stent, made by ...

Terumo's drug-eluting stent, Nobori, nabbed a bit of Abbott Laboratories' ($ABT) Xience glory as it proved in a large study to be just as effective as the top-selling ...

NEW ORLEANS, March 24 (Reuters) - An experimental drug-coated stent from Abbott Laboratories Inc. designed to be fully absorbed by the body appeared to be safe and effective in a tiny early-stage ...